Recent Finacing
Recent Raise
Atsena Therapeutics develops AAV-based gene therapies for inherited retinal diseases, advancing multiple programs (including ATSN-201 and ATSN-101) through clinical trials, manufacturing development, and pharma partnerships.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
